Validated treatments and therapeutics prospectives regarding pharmacological products for sarcopenia

[1]  S. Conger,et al.  Does caffeine added to carbohydrate provide additional ergogenic benefit for endurance? , 2011, International journal of sport nutrition and exercise metabolism.

[2]  K. Nair,et al.  The effects of growth hormone and/or testosterone on whole body protein kinetics and skeletal muscle gene expression in healthy elderly men: a randomized controlled trial. , 2008, The Journal of clinical endocrinology and metabolism.

[3]  J. E. Morley,et al.  Sarcopenia: Its assessment, etiology, pathogenesis, consequences and future perspectives , 2008, The journal of nutrition, health & aging.

[4]  K. Fargo,et al.  Androgen regulates neuritin mRNA levels in an in vivo model of steroid-enhanced peripheral nerve regeneration. , 2008, Journal of neurotrauma.

[5]  B. Hurley,et al.  ACE genotype and the muscle hypertrophic and strength responses to strength training. , 2008, Medicine and science in sports and exercise.

[6]  K. Matthews,et al.  Mechano-growth factor reduces loss of cardiac function in acute myocardial infarction. , 2008, Heart, lung & circulation.

[7]  A. Bitto,et al.  Simvastatin enhances VEGF production and ameliorates impaired wound healing in experimental diabetes. , 2008, Pharmacological research.

[8]  A. Gliozzi,et al.  The role of the polyglutamine tract in androgen receptor , 2008, The Journal of Steroid Biochemistry and Molecular Biology.

[9]  D. Grobbee,et al.  Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial. , 2008, JAMA.

[10]  E. Bleecker,et al.  Interaction between Angiotensin Converting Enzyme Insertion/Deletion Genotype and Exercise Training on Knee Extensor Strength in Older Individuals , 2007, International journal of sports medicine.

[11]  R. Silver,et al.  A role for androgens in regulating circadian behavior and the suprachiasmatic nucleus. , 2007, Endocrinology.

[12]  M. Mcmurdo,et al.  Effect of perindopril on physical function in elderly people with functional impairment: a randomized controlled trial , 2007, Canadian Medical Association Journal.

[13]  S. Sheather,et al.  Statins and dietary and serum cholesterol are associated with increased lean mass following resistance training. , 2007, The journals of gerontology. Series A, Biological sciences and medical sciences.

[14]  N. Rosenthal,et al.  Enhancing Repair of the Mammalian Heart , 2007, Circulation research.

[15]  N. Rosenthal,et al.  Local expression of IGF‐1 accelerates muscle regeneration by rapidly modulating inflammatory cytokines and chemokines , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[16]  D. Judge,et al.  Angiotensin II type 1 receptor blockade attenuates TGF-β–induced failure of muscle regeneration in multiple myopathic states , 2007, Nature Medicine.

[17]  Wenqing Gao,et al.  Expanding the therapeutic use of androgens via selective androgen receptor modulators (SARMs). , 2007, Drug discovery today.

[18]  J. Concato,et al.  Effects of Statin Use on Muscle Strength, Cognition, and Depressive Symptoms in Older Adults , 2007, Journal of the American Geriatrics Society.

[19]  M. Cesari,et al.  Use of ACE inhibitors is associated with elevated levels of IGFBP-3 among hypertensive older adults: results from the IlSIRENTE study , 2007, European Journal of Clinical Pharmacology.

[20]  G. Ostir,et al.  Androgen Treatment and Muscle Strength in Elderly Men: A Meta‐Analysis , 2006, Journal of the American Geriatrics Society.

[21]  J. Schertzer,et al.  Systemic administration of IGF-I enhances oxidative status and reduces contraction-induced injury in skeletal muscles of mdx dystrophic mice. , 2006, American journal of physiology. Endocrinology and metabolism.

[22]  J. Schertzer,et al.  Comparative evaluation of IGF-I gene transfer and IGF-I protein administration for enhancing skeletal muscle regeneration after injury , 2006, Gene Therapy.

[23]  M. Guida,et al.  Serum leptin levels and body composition in postmenopausal women treated with tibolone and raloxifene , 2006, Menopause.

[24]  Matthew A. Kostek,et al.  ACE ID genotype and the muscle strength and size response to unilateral resistance training. , 2006, Medicine and science in sports and exercise.

[25]  M. Pahor,et al.  Effects of ACE inhibitors on skeletal muscle. , 2006, Current pharmaceutical design.

[26]  S. Bandinelli,et al.  Relation of angiotensin-converting enzyme inhibitor treatment to insulin-like growth factor-1 serum levels in subjects >65 years of age (the InCHIANTI study). , 2006, The American journal of cardiology.

[27]  P. Sestili,et al.  Creatine supplementation affords cytoprotection in oxidatively injured cultured mammalian cells via direct antioxidant activity. , 2006, Free radical biology & medicine.

[28]  F. Martin,et al.  The effects of growth hormone and/or testosterone in healthy elderly men: a randomized controlled trial. , 2006, The Journal of clinical endocrinology and metabolism.

[29]  A. Kenny,et al.  Effects of Ultra‐Low‐Dose Estrogen Therapy on Muscle and Physical Function in Older Women , 2005, Journal of the American Geriatrics Society.

[30]  P. Roberson,et al.  Effects of muscle strength training and testosterone in frail elderly males. , 2005, Medicine and science in sports and exercise.

[31]  A. LaCroix,et al.  Postmenopausal hormone therapy and body composition—a substudy of the estrogen plus progestin trial of the Women's Health Initiative , 2005 .

[32]  B. Caballero,et al.  Effects of growth hormone and/or sex steroid administration on whole-body protein turnover in healthy aged women and men. , 2005, Metabolism: clinical and experimental.

[33]  M. Boyanov,et al.  Effects of tibolone on body composition in postmenopausal women: a 1-year follow up study. , 2005, Maturitas.

[34]  M. Esbjörnsson,et al.  Oestrogen receptor β is present in both muscle fibres and endothelial cells within human skeletal muscle tissue , 2005, Histochemistry and Cell Biology.

[35]  S. Rubin,et al.  Angiotensin-converting enzyme insertion/deletion genotype, exercise, and physical decline. , 2005, JAMA.

[36]  M. Bemben,et al.  Does Nutritional Supplementation Influence Adaptability of Muscle to Resistance Training in Men Aged 48 to 72 Years , 2005, Journal of geriatric physical therapy.

[37]  M. J. Toth,et al.  The effect of hormone replacement therapy on body composition, body fat distribution, and insulin sensitivity in menopausal women: a randomized, double-blind, placebo-controlled trial. , 2005, The Journal of clinical endocrinology and metabolism.

[38]  A. Matsumoto,et al.  Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T. , 2005, The Journal of clinical endocrinology and metabolism.

[39]  G. Goldspink,et al.  Growth factors and muscle ageing , 2004, Experimental Gerontology.

[40]  G. Bifulco,et al.  Serum leptin levels and body composition in postmenopausal women: effects of hormone therapy , 2004, Menopause.

[41]  J. Williamson,et al.  Antihypertensive Medications and Differences in Muscle Mass in Older Persons: The Health, Aging and Body Composition Study , 2004, Journal of the American Geriatrics Society.

[42]  C. Stewart,et al.  Differential signalling mechanisms predisposing primary human skeletal muscle cells to altered proliferation and differentiation: roles of IGF-I and TNFalpha. , 2004, Experimental cell research.

[43]  E. Hawe,et al.  Bradykinin receptor gene variant and human physical performance. , 2004, Journal of applied physiology.

[44]  G. Onder,et al.  Pharmacoepidemiology and disability in older adults: can medications slow the age-related decline in physical function? , 2004, Expert opinion on pharmacotherapy.

[45]  S. Bhasin,et al.  Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3H 10T1/2 pluripotent cells through an androgen receptor-mediated pathway. , 2003, Endocrinology.

[46]  S. Aedo,et al.  Efecto diferencial sobre el IGF-1 sérico de tibolona (5 mg/día) vs combinado continuo de estrógeno/progestina en mujeres postmenopáusicas , 2003 .

[47]  K. Christensen,et al.  ACE genotype and physical training effects: A randomized study among elderly Danes , 2003, Aging clinical and experimental research.

[48]  R. Porcher,et al.  Changes in body composition during post-menopausal hormone therapy: a 2 year prospective study. , 2003, Human reproduction.

[49]  R. Dom,et al.  Effects of creatine supplementation and exercise training on fitness in men 55-75 yr old. , 2003, Journal of applied physiology.

[50]  Matthew T. Haren,et al.  Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal status. , 2003, The journals of gerontology. Series A, Biological sciences and medical sciences.

[51]  Alun Jones,et al.  Skeletal muscle RAS and exercise performance. , 2003, The international journal of biochemistry & cell biology.

[52]  J. Rosene,et al.  Effects of oral creatine and resistance training on myogenic regulatory factor expression. , 2003, Medicine and science in sports and exercise.

[53]  S. Going,et al.  Effects of exercise training and hormone replacement therapy on lean and fat mass in postmenopausal women. , 2003, The journals of gerontology. Series A, Biological sciences and medical sciences.

[54]  P. Delamarche,et al.  Estrogen receptor alpha mRNA in human skeletal muscles. , 2003, Medicine and science in sports and exercise.

[55]  S. Miura,et al.  The I allele of the angiotensin‐converting enzyme gene is associated with an increased percentage of slow‐twitch type I fibers in human skeletal muscle , 2003, Clinical genetics.

[56]  P. Vestergaard,et al.  Hormone Replacement Therapy Dissociates Fat Mass and Bone Mass, and Tends to Reduce Weight Gain in Early Postmenopausal Women: A Randomized Controlled 5‐Year Clinical Trial of the Danish Osteoporosis Prevention Study , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[57]  J. Vaupel,et al.  Angiotensin I-converting enzyme (ACE) gene polymorphism in relation to physical performance, cognition and survival--a follow-up study of elderly Danish twins. , 2003, Annals of epidemiology.

[58]  Gianni Parise,et al.  Creatine supplementation enhances isometric strength and body composition improvements following strength exercise training in older adults. , 2003, The journals of gerontology. Series A, Biological sciences and medical sciences.

[59]  S. Bhasin,et al.  Effects of an oral androgen on muscle and metabolism in older, community-dwelling men. , 2003, American journal of physiology. Endocrinology and metabolism.

[60]  R. Wolfe,et al.  Differential anabolic effects of testosterone and amino acid feeding in older men. , 2003, The Journal of clinical endocrinology and metabolism.

[61]  Suzanne G. Leveille,et al.  Change in Muscle Strength Explains Accelerated Decline of Physical Function in Older Women With High Interleukin‐6 Serum Levels , 2002, Journal of the American Geriatrics Society.

[62]  J. Patrie,et al.  Single and combined effects of growth hormone and testosterone administration on measures of body composition, physical performance, mood, sexual function, bone turnover, and muscle gene expression in healthy older men. , 2002, The Journal of clinical endocrinology and metabolism.

[63]  J. Sorkin,et al.  Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial. , 2002 .

[64]  L. Ignarro,et al.  Effects of tibolone on plasma levels of nitric oxide in postmenopausal women. , 2002, Fertility and sterility.

[65]  E. Ribom,et al.  Six months of hormone replacement therapy does not influence muscle strength in postmenopausal women. , 2002, Maturitas.

[66]  AndrewJ. S. Coats.  MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial , 2002, The Lancet.

[67]  G. Goldspink,et al.  Different roles of the IGF‐I Ec peptide (MGF) and mature IGF‐I in myoblast proliferation and differentiation , 2002, FEBS letters.

[68]  R. Casaburi,et al.  Testosterone-induced increase in muscle size in healthy young men is associated with muscle fiber hypertrophy. , 2002, American journal of physiology. Endocrinology and metabolism.

[69]  A. Musarò,et al.  Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice , 2002, The Journal of cell biology.

[70]  J. Williamson,et al.  Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women: an observational study , 2002, The Lancet.

[71]  Craig R Denegar,et al.  Creatine supplementation improves muscular performance in older men. , 2002, Medicine and science in sports and exercise.

[72]  C. Christiansen,et al.  The effect of hormone replacement therapy on appendicular lean tissue mass in early postmenopausal women , 2002, Menopause.

[73]  R. Wolfe,et al.  Testosterone administration to older men improves muscle function: molecular and physiological mechanisms. , 2002, American journal of physiology. Endocrinology and metabolism.

[74]  S. Humphries,et al.  Impact of angiotensin converting enzyme inhibition on post-coronary artery bypass interleukin 6 release , 2002, Heart.

[75]  J. Bülow,et al.  GH administration changes myosin heavy chain isoforms in skeletal muscle but does not augment muscle strength or hypertrophy, either alone or combined with resistance exercise training in healthy elderly men. , 2002, The Journal of clinical endocrinology and metabolism.

[76]  J. Lawler,et al.  Direct antioxidant properties of creatine. , 2002, Biochemical and biophysical research communications.

[77]  M. Samson,et al.  Muscle strength and tibolone: a randomised, double‐blind, placebo‐controlled trial , 2002, BJOG : an international journal of obstetrics and gynaecology.

[78]  S. Yusuf.  MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Commentary , 2002 .

[79]  K. Chad,et al.  Creatine supplementation combined with resistance training in older men. , 2001, Medicine and science in sports and exercise.

[80]  Christianna S. Williams,et al.  Functional disability and health care expenditures for older persons. , 2001, Archives of internal medicine.

[81]  M. Samson,et al.  The effect of tibolone on fat mass, fat-free mass, and total body water in postmenopausal women. , 2001, Endocrinology.

[82]  N. Madias,et al.  3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors Upregulate Inducible NO Synthase Expression and Activity in Vascular Smooth Muscle Cells , 2001, Hypertension.

[83]  S. Takeshita,et al.  Angiotensin-converting enzyme inhibition improves defective angiogenesis in the ischemic limb of spontaneously hypertensive rats. , 2001, Cardiovascular research.

[84]  B. Ottesen,et al.  Obesity and sarcopenia after menopause are reversed by sex hormone replacement therapy. , 2001, Obesity research.

[85]  N. Tomilin,et al.  The angiotensin converting enzyme I/D polymorphism in Russian athletes , 2001, European Journal of Human Genetics.

[86]  David Handelsman,et al.  A double-blind, placebo-controlled, randomized clinical trial of transdermal dihydrotestosterone gel on muscular strength, mobility, and quality of life in older men with partial androgen deficiency. , 2001, The Journal of clinical endocrinology and metabolism.

[87]  K. Yarasheski,et al.  Effects of acute creatine monohydrate supplementation on leucine kinetics and mixed-muscle protein synthesis. , 2001, Journal of applied physiology.

[88]  H. Suominen,et al.  Effects of hormone replacement therapy and high-impact physical exercise on skeletal muscle in post-menopausal women: a randomized placebo-controlled study. , 2001, Clinical science.

[89]  D. Kiel,et al.  Growth Hormone Administration and Exercise Effects on Muscle Fiber Type and Diameter in Moderately Frail Older People , 2001, Journal of the American Geriatrics Society.

[90]  Paul M. Ridker,et al.  Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. , 2001, The New England journal of medicine.

[91]  K. Chad,et al.  EFFECT OF CREATINE SUPPLEMENTATION COMBINED WITH RESISTANCE TRAINING ON WHOLE BODY BONE MINERAL IN OLDER MEN , 2001 .

[92]  A. Kenny,et al.  Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.

[93]  J. Chrast,et al.  Angiotensin II induces skeletal muscle wasting through enhanced protein degradation and down-regulates autocrine insulin-like growth factor I. , 2001, Endocrinology.

[94]  Hugh Montgomery,et al.  Elite swimmers and the D allele of the ACE I/D polymorphism , 2001, Human Genetics.

[95]  Antonio Musarò,et al.  Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle , 2001, Nature Genetics.

[96]  S. Fagan,et al.  Pharmacology and clinical experience with simvastatin , 2001, Expert opinion on pharmacotherapy.

[97]  P. Ridker,et al.  Are statins anti-inflammatory? , 2000, Current controlled trials in cardiovascular medicine.

[98]  David A Jones,et al.  Angiotensin‐Converting Enzyme Genotype Affects the Response of Human Skeletal Muscle to Functional Overload , 2000, Experimental physiology.

[99]  C. Bouchard,et al.  No association between the angiotensin-converting enzyme ID polymorphism and elite endurance athlete status. , 2000, Journal of applied physiology.

[100]  J. E. Anderson,et al.  A role for nitric oxide in muscle repair: nitric oxide-mediated activation of muscle satellite cells. , 2000, Molecular biology of the cell.

[101]  H. E. Montgomery,et al.  Physiology: The ACE gene and muscle performance , 2000, Nature.

[102]  K. Williams,et al.  Three-dimensional structure of the ion-coupled transport protein NhaA , 2000, Nature.

[103]  P. Clarkson,et al.  Acute Creatine Supplementation in Older Men , 2000, International journal of sports medicine.

[104]  K. Chihara,et al.  Effect of recombinant human growth hormone in elderly osteoporotic women , 1999, Clinical endocrinology.

[105]  H Hemingway,et al.  Human angiotensin I-converting enzyme gene and endurance performance. , 1999, Journal of applied physiology.

[106]  P. Vestergaard,et al.  Hormone replacement therapy affects body composition and leptin differently in obese and non-obese postmenopausal women. , 1999, The Journal of endocrinology.

[107]  C. Mamotte,et al.  Elite athletes and the gene for angiotensin-converting enzyme. , 1999, Journal of applied physiology.

[108]  J. Berlin,et al.  Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. , 1999, The Journal of clinical endocrinology and metabolism.

[109]  M. Horan,et al.  Difficulties in measuring the effect of testosterone replacement therapy on muscle function in older men. , 1999, International journal of andrology.

[110]  J. Schaper,et al.  Effect of long-term ACE inhibition on myocardial tissue in hypertensive stroke-prone rats. , 1999, Journal of molecular and cellular cardiology.

[111]  M. Pfeffer,et al.  Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein , 1999 .

[112]  Shekhar Saxena,et al.  Multiple-informant ranking of the disabling effects of different health conditions in 14 countries , 1999, The Lancet.

[113]  P. Libby,et al.  Angiotensin induces inflammatory activation of human vascular smooth muscle cells. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[114]  J. Isner,et al.  Tissue inhibition of angiotensin-converting enzyme activity stimulates angiogenesis in vivo. , 1999, Circulation.

[115]  M. Francaux,et al.  Effects of training and creatine supplement on muscle strength and body mass , 1999, European Journal of Applied Physiology and Occupational Physiology.

[116]  P. Clarkson,et al.  Effects of 30 days of creatine ingestion in older men , 1999, European Journal of Applied Physiology and Occupational Physiology.

[117]  M. Runge,et al.  Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-kappa B transcription factors. , 1999, Circulation research.

[118]  R. Woledge,et al.  Hormone replacement therapy increases isometric muscle strength of adductor pollicis in post-menopausal women. , 1999, Clinical science.

[119]  Ole A. Andreassen,et al.  Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis , 1999, Nature Medicine.

[120]  Jimmy D Bell,et al.  Angiotensin-converting-enzyme gene insertion/deletion polymorphism and response to physical training , 1999, The Lancet.

[121]  M. Volterrani,et al.  Improved exercise tolerance after losartan and enalapril in heart failure: correlation with changes in skeletal muscle myosin heavy chain composition. , 1998, Circulation.

[122]  S. Bermon,et al.  Effects of creatine monohydrate ingestion in sedentary and weight-trained older adults. , 1998, Acta physiologica Scandinavica.

[123]  W. Parmley,et al.  Evolution of angiotensin-converting enzyme inhibition in hypertension, heart failure, and vascular protection. , 1998, The American journal of medicine.

[124]  Bing Yu,et al.  Elite endurance athletes and the ACE I allele – the role of genes in athletic performance , 1998, Human Genetics.

[125]  F. Horber,et al.  Differential impact of conventional oral or transdermal hormone replacement therapy or tibolone on body composition in postmenopausal women , 1998, Clinical endocrinology.

[126]  Jimmy D Bell,et al.  Human gene for physical performance , 1998, Nature.

[127]  J. Yesavage,et al.  Effects of human growth hormone, insulin-like growth factor I, and diet and exercise on body composition of obese postmenopausal women. , 1998, The Journal of clinical endocrinology and metabolism.

[128]  F. Petraglia,et al.  Modulatory effects of a synthetic steroid (tibolone) and estradiol on spontaneous and GH-RH-induced GH secretion in postmenopausal women. , 1997, Maturitas.

[129]  G. Delitala,et al.  Effects of six-month administration of recombinant human growth hormone to healthy elderly subjects , 1997, Aging.

[130]  H. Perry,et al.  Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. , 1997, The Journal of clinical endocrinology and metabolism.

[131]  L. Moldawer,et al.  Proinflammatory cytokines, nutritional support, and the cachexia syndrome , 1997, Cancer.

[132]  J. Heikkinen,et al.  HRT and exercise: effects on bone density, muscle strength and lipid metabolism. A placebo controlled 2-year prospective trial on two estrogen-progestin regimens in healthy postmenopausal women. , 1997, Maturitas.

[133]  M B Macpherson,et al.  Effects of hormone replacement therapy on muscle performance and balance in post-menopausal women. , 1996, Clinical science.

[134]  S. Welle,et al.  Growth hormone increases muscle mass and strength but does not rejuvenate myofibrillar protein synthesis in healthy subjects over 60 years old. , 1996, The Journal of clinical endocrinology and metabolism.

[135]  E. Böhme,et al.  Polymorphisms in the gene for the human B2-bradykinin receptor. New tools in assessing a genetic risk for bradykinin-associated diseases. , 1996, Immunopharmacology.

[136]  M. Brink,et al.  Angiotensin II causes weight loss and decreases circulating insulin-like growth factor I in rats through a pressor-independent mechanism. , 1996, The Journal of clinical investigation.

[137]  M. Schambelan,et al.  Growth Hormone Replacement in Healthy Older Men Improves Body Composition but Not Functional Ability , 1996, Annals of Internal Medicine.

[138]  L. Fried,et al.  Disability as a public health outcome in the aging population. , 1996, Annual review of public health.

[139]  H. Schunkert,et al.  Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. , 1995, Circulation.

[140]  B. Sjödin,et al.  Skeletal muscle metabolism during short duration high-intensity exercise: influence of creatine supplementation. , 1995, Acta physiologica Scandinavica.

[141]  M. Sheehan,et al.  The influence of menopause and hormonal replacement therapy on body cell mass and body fat mass. , 1995, American journal of obstetrics and gynecology.

[142]  K. Yarasheski,et al.  Effect of growth hormone and resistance exercise on muscle growth and strength in older men. , 1995, The American journal of physiology.

[143]  R L Hintz,et al.  Effect of recombinant human growth hormone on the muscle strength response to resistance exercise in elderly men. , 1994, The Journal of clinical endocrinology and metabolism.

[144]  U. Keller,et al.  Comparison of the effects of recombinant human insulin-like growth factor-I and insulin on glucose and leucine kinetics in humans. , 1993, The Journal of clinical investigation.

[145]  J. S. Tenover,et al.  Effects of testosterone supplementation in the aging male. , 1992, The Journal of clinical endocrinology and metabolism.

[146]  C. Christiansen,et al.  Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. , 1991, Metabolism: clinical and experimental.

[147]  N. Levens.  Local control of jejunal absorption by the renin-angiotensin system. , 1986, Journal of cardiovascular pharmacology.

[148]  J. Ingwall.  Creatine and the Control of Muscle‐Specific Protein Synthesis in Cardiac and Skeletal Muscle , 1976, Circulation research.

[149]  J. Bigger,et al.  The Effect of Procaine Amide on Components of Excitability in Long Mammalian Cardiac Purkinje Fibers , 1976, Circulation research.

[150]  M. Morales,et al.  SPECIFICITY OF CREATINE IN THE CONTROL OF MUSCLE PROTEIN SYNTHESIS , 1974, The Journal of cell biology.